What is the treatment approach for a patient with a chronic obstructive pulmonary disease (COPD) exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

COPD Exacerbation Order Set for Hospitalized Patients

For hospitalized patients with COPD exacerbation, immediately initiate combined short-acting bronchodilators, systemic corticosteroids for exactly 5 days, controlled oxygen targeting 88-92%, and antibiotics when indicated by cardinal symptoms. 1

Initial Assessment Orders

Vital Signs and Monitoring

  • Continuous pulse oximetry with target SpO2 88-92% 1
  • Arterial blood gas within 1 hour of oxygen initiation (mandatory to assess for hypercapnia and acidosis) 1
  • Vital signs every 4 hours initially 2
  • Cardiac monitoring if arrhythmia suspected 2

Laboratory Studies

  • Complete blood count with differential (assess eosinophil count if available - ≥2% predicts better corticosteroid response) 3
  • Basic metabolic panel (monitor for hyperglycemia from steroids) 3
  • Brain natriuretic peptide if heart failure suspected 2
  • Sputum culture if purulent sputum present 2

Imaging

  • Chest X-ray to exclude pneumonia, pneumothorax, or heart failure 2

Oxygen Therapy Orders

Controlled Oxygen Delivery

  • Start with 28% Venturi mask or 2 L/min nasal cannula 4
  • Target SpO2 88-92% (NOT 90-93% as in other conditions) 1
  • Recheck ABG within 1 hour to ensure no worsening hypercapnia or acidosis 1
  • Adjust FiO2 to maintain PaO2 ≥60 mmHg (8 kPa) without causing CO2 retention 2

Bronchodilator Orders

Nebulized Therapy (Preferred for Hospitalized Patients)

  • Albuterol 2.5-5 mg PLUS ipratropium 0.25-0.5 mg via nebulizer every 4-6 hours 1
  • Continue regular dosing (not PRN) during acute phase for first 24-48 hours 1
  • May space to every 6 hours once clinical improvement occurs 2

Alternative: MDI with Spacer

  • Albuterol 2 puffs (180 mcg) PLUS ipratropium 2 puffs (36 mcg) every 4-6 hours 2
  • Note: Nebulizers preferred in sicker patients as they avoid need for 20+ coordinated inhalations 1

DO NOT ORDER:

  • Theophylline or aminophylline (no added benefit, increased side effects) 2, 4

Systemic Corticosteroid Orders

Standard Regimen

  • Prednisone 40 mg PO once daily for EXACTLY 5 days 1, 4, 3
  • Alternative: Prednisolone 30-40 mg PO once daily for 5 days 2, 1
  • Do NOT extend beyond 5-7 days (no additional benefit, increased adverse effects) 1, 3

If Patient Cannot Take Oral Medications

  • Methylprednisolone 40 mg IV once daily 1, 3
  • Alternative: Hydrocortisone 100 mg IV every 6-8 hours 2, 3
  • Switch to oral as soon as patient can tolerate 3

Critical Point: Oral route equally effective to IV and preferred when possible 2, 3

Antibiotic Orders (When Indicated)

Indications for Antibiotics 1, 4

  • Presence of 2 or more cardinal symptoms:
    • Increased sputum purulence (most important)
    • Increased dyspnea
    • Increased sputum volume

First-Line Antibiotic Choices (5-7 days) 2, 1

  • Amoxicillin-clavulanate 875/125 mg PO twice daily, OR
  • Azithromycin 500 mg PO day 1, then 250 mg daily days 2-5, OR
  • Doxycycline 100 mg PO twice daily

For Treatment Failure or Risk Factors for Pseudomonas 2

  • Levofloxacin 750 mg PO/IV once daily, OR
  • Moxifloxacin 400 mg PO/IV once daily

Respiratory Support Orders

Noninvasive Ventilation (NIV) - First-Line for Respiratory Failure 2, 4

Indications for NIV:

  • Acute hypercapnic respiratory failure (pH <7.35 with PaCO2 >45 mmHg) 1
  • Persistent hypoxemia despite oxygen 1
  • Severe dyspnea with respiratory muscle fatigue 1
  • Respiratory rate >25 breaths/minute 2

NIV Settings (Initial):

  • BiPAP mode: IPAP 10-12 cm H2O, EPAP 4-5 cm H2O 1
  • Titrate IPAP to achieve tidal volume 6-8 mL/kg and patient comfort 1
  • FiO2 to maintain SpO2 88-92% 1

Contraindications to NIV:

  • Altered mental status/inability to protect airway 1
  • Hemodynamic instability 2
  • Recent facial/upper airway surgery 2
  • Copious secretions patient cannot clear 1

Supportive Care Orders

Venous Thromboembolism Prophylaxis

  • Enoxaparin 40 mg subcutaneous once daily (if CrCl >30) 1
  • Alternative: Heparin 5000 units subcutaneous every 8-12 hours 1

Fluid Management

  • Monitor fluid balance carefully 2
  • Diuretics ONLY if peripheral edema AND elevated JVP present 1
  • Avoid overhydration (worsens respiratory status) 2

Nutrition

  • Regular diet as tolerated 2
  • Nutritional consultation if malnourished 2

DO NOT ORDER:

  • Chest physiotherapy (no evidence of benefit in acute exacerbations) 1

Discharge Planning Orders (Initiate on Day 1)

Before Discharge, Patient Must Have:

  • Long-acting bronchodilator therapy initiated (LAMA, LABA, or combination) 2, 4
  • Inhaler technique verified and documented 1
  • Pulmonary rehabilitation referral scheduled within 3 weeks of discharge 1
  • Follow-up appointment within 3-7 days 1
  • Smoking cessation counseling if current smoker 1

Discharge Medications to Prescribe:

  • Continue or initiate triple therapy (LAMA/LABA/ICS) if ≥2 exacerbations per year 1
  • Albuterol MDI 2 puffs every 4-6 hours PRN for rescue 1
  • Do NOT continue systemic corticosteroids beyond 5-7 days 3

Common Pitfalls to Avoid

Critical Errors:

  • Extending corticosteroids beyond 5-7 days (increases adverse effects without benefit) 1, 3
  • Using high-flow oxygen without monitoring ABG (risk of CO2 retention) 1
  • Delaying NIV in patients with respiratory failure (increases intubation risk and mortality) 1
  • Prescribing antibiotics without cardinal symptoms present (unnecessary exposure) 1
  • Using theophylline (no benefit, significant side effects) 2, 4
  • Defaulting to IV corticosteroids when oral route available (increased costs and adverse effects without improved outcomes) 3

Documentation Requirements:

  • Document number of cardinal symptoms present (determines antibiotic indication) 1
  • Document baseline functional status and degree of worsening 1
  • Document exacerbation frequency over past year (determines discharge therapy) 1
  • Document smoking status and cessation counseling provided 1

References

Guideline

COPD Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Corticosteroid Treatment for COPD Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of COPD Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.